Effect of the α4β7 integrin blocking antibody vedolizumab on the clinical and host immune response in patients with inflammatory bowel disease

Files in this item

This item appears in the following Collection(s)

© 2021, Ciaran Judge. Except where otherwise noted, this item's license is described as © 2021, Ciaran Judge.
This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement